We will in brief review here a) the actions of tetrac—and, in some cases, thyroid hormone—on cancer cell radiosensitivity and b) the effects of Nanotetrac on the signaling pathways relevant to the radiation sensitivity state of tumor cells. The gene discussed is TG; the disease is cancer.